These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37812301)

  • 1. Alterations of Audiovisual Integration in Alzheimer's Disease.
    Liu Y; Wang Z; Wei T; Zhou S; Yin Y; Mi Y; Liu X; Tang Y
    Neurosci Bull; 2023 Dec; 39(12):1859-1872. PubMed ID: 37812301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed audiovisual integration of patients with mild cognitive impairment and Alzheimer's disease compared with normal aged controls.
    Wu J; Yang J; Yu Y; Li Q; Nakamura N; Shen Y; Ohta Y; Yu S; Abe K
    J Alzheimers Dis; 2012; 32(2):317-28. PubMed ID: 22810093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociable Effects of Aging and Mild Cognitive Impairment on Bottom-Up Audiovisual Integration.
    Festa EK; Katz AP; Ott BR; Tremont G; Heindel WC
    J Alzheimers Dis; 2017; 59(1):155-167. PubMed ID: 28598838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease.
    Badea A; Delpratt NA; Anderson RJ; Dibb R; Qi Y; Wei H; Liu C; Wetsel WC; Avants BB; Colton C
    Magn Reson Imaging; 2019 Jul; 60():52-67. PubMed ID: 30940494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.
    Daulatzai MA
    Neurotox Res; 2016 Oct; 30(3):295-337. PubMed ID: 27339162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples.
    Doan NT; Engvig A; Zaske K; Persson K; Lund MJ; Kaufmann T; Cordova-Palomera A; Alnæs D; Moberget T; Brækhus A; Barca ML; Nordvik JE; Engedal K; Agartz I; Selbæk G; Andreassen OA; Westlye LT;
    Neuroimage; 2017 Sep; 158():282-295. PubMed ID: 28666881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    Xiong Y; Ye C; Sun R; Chen Y; Zhong X; Zhang J; Zhong Z; Chen H; Huang M
    Curr Alzheimer Res; 2023; 20(3):161-174. PubMed ID: 37278043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
    Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.
    Liddell BJ; Paul RH; Arns M; Gordon N; Kukla M; Rowe D; Cooper N; Moyle J; Williams LM
    J Integr Neurosci; 2007 Mar; 6(1):141-74. PubMed ID: 17472227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
    Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease.
    Demirtaş M; Falcon C; Tucholka A; Gispert JD; Molinuevo JL; Deco G
    Neuroimage Clin; 2017; 16():343-354. PubMed ID: 28861336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual-somatosensory integration (VSI) as a novel marker of Alzheimer's disease: A comprehensive overview of the VSI study.
    Mahoney JR; Blumen HM; De Sanctis P; Fleysher R; Frankini C; Hoang A; Hoptman MJ; Jin R; Lipton M; Nunez V; Twizer L; Uy N; Valdivia A; Verghese T; Wang C; Weiss EF; Zwerling J; Verghese J
    Front Aging Neurosci; 2023; 15():1125114. PubMed ID: 37065459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependency criterion based brain pathological age estimation of Alzheimer's disease patients with MR scans.
    Li Y; Liu Y; Wang P; Wang J; Xu S; Qiu M;
    Biomed Eng Online; 2017 Apr; 16(1):50. PubMed ID: 28438167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration.
    Fang R; Yan XX; Wu ZY; Sun Y; Yin QH; Wang Y; Tang HD; Sun JF; Miao F; Chen SD
    Curr Alzheimer Res; 2015; 12(6):572-84. PubMed ID: 26027816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.